SEARCH

Business » Industry

Updated: April 10, 2013 00:32 IST

Novartis has no reason to complain: Anand Sharma

Sujay Mehdudia
Comment (1)   ·   print   ·   T  T  
Anand Sharma
Anand Sharma

Stating that Novartis had no reason to complain and everything had been done under the legal process, Commerce and Industry Minister, Anand Sharma on Tuesday said constitutional offices are not expected to dictate or determine judicial pronouncements but respect the same.

Talking to The Hindu over phone from Geneva, Mr. Sharma wondered why India was being faulted for following the judicial process and respecting the verdict of the highest court. “We have followed a legal process in the High Court and Supreme Court. We have a Patent Act in place in the country. We are committed to innovation and research but will have to find the right kind of balance between the social obligation of providing cheap and accessible drugs to the poor and weak sections of the population and looking after the interests of companies involved in the pharmaceutical sector,’’ he remarked.

Mr. Sharma, who spoke at the World Intellectual Property Organization in Geneva on Monday evening, said Novartis is the third largest beneficiary of registered patents in India, behind Roche and Sanofi, with 147 patents to its name in the country.

“Why India is not being respected for having granted the 147 patents to the same company rather than triggering off a debate on why Indian judiciary has denied something in one case,” he asked.

Stating that India was firmly committed to protecting intellectual property, he pointed out that those applying for patents in the country had more than doubled in the last five years.

“On one hand we have a large number of companies who have invested billions in research, in developing new molecules, in new drug discoveries and in research. On the other hand, there is a social obligation to provide affordable and cheap drugs and healthcare. We have to strike the right balance,” he added.

Mr. Sharma said that Novartis had been denied the patent or ever-greening under the law of the country and it was completely justified. He said the massive manufacturing of generic drugs in the country had been instrumental in bringing down the cost dramatically and increasing the availability of life saving drugs to combat various diseases including AIDS and cancer.

More In: Industry | Business

Well said Mr. Sharma. One can't keep the cake and eat it too! The west
will praise India for its 'independent judiciary' when its suits them;
otherwise its a case of 'poor legislation'. This case comes at time when
the global power equations undergo major and inexorable changes. I'm
sure more countries will follow India's example from this case.

from:  shaista
Posted on: Apr 10, 2013 at 15:54 IST
This article is closed for comments.
Please Email the Editor
Both the tech giants have now decided to drop the patent cases in all other countries except U.S. Photo: AP

Timeline: Apple and Samsung patent game-play

2007: Apple sued its component supplier Samsung for four design patents, which included the basic shape of iPhone. It declared that most of the South Korean Company's android phon... »

National

International

Sport


O
P
E
N

close

Recent Article in Industry

Maruti Dzire

Maruti to recall 69,555 units of old Dzire and Swift, Ritz

This exercise is limited to vehicles within the above specified range and does not pertain to any other vehicle of the company or its exports, it added. »